March 28 – 30, 2023 | San Diego, CA
The 8th Innate Killer Summit returns to San Diego in March to cement your end-to-end education in innate immune therapeutics. This year’s meeting brings critical insights and updates for your whole team, with content tracks spanning preclinical development, clinical translation, CMC, process development, and clinical scale manufacturing.
Engage in interactive discussion and network with 250+ innate immune experts from 120+ companies to realize lasting clinical response with next-generation engineering to provide off-the-shelf delivery for more patients globally.
Providing a landscape review of innate immune therapies, is Beacon’s own Research Analyst, Flavio Lima Bianchi, where he will take a deep dive into the drug landscape including analysis of drug developers and innovative technologies and provide a look to the future based on expected regulatory events
